The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis

BACKGROUND: Current WHO guidelines (2018) recommend screening for cryptococcal antigen (CrAg) in HIV-infected persons with CD4+ T cell counts< 100 cells/μL, followed by pre-emptive antifungal therapy among CrAg positive (CrAg+) persons, to prevent cryptococcal meningitis related deaths. This stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yao, Huang, Xiaojie, Chen, Hui, Qin, Yuanyuan, Hou, Jianhua, Li, Aixin, Wu, Hao, Yan, Xiaofeng, Chen, Yaokai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291520/
https://www.ncbi.nlm.nih.gov/pubmed/32532212
http://dx.doi.org/10.1186/s12879-020-05126-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291520/
https://www.ncbi.nlm.nih.gov/pubmed/32532212
http://dx.doi.org/10.1186/s12879-020-05126-z

Ejemplares similares